![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 9, 5306-5316, February 29, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



1
From the
Department of Molecular Medicine, College of Veterinary Medicine and
Department of Applied Engineering and Physics, Cornell University, Ithaca, New York 14853-6401
The effects of norepinephrine (NE), an inhibitor of insulin secretion, were examined on membrane potential and the ATP-sensitive K+ channel (KATP) in INS 832/13 cells. Membrane potential was monitored under the whole cell current clamp mode. NE hyperpolarized the cell membrane, an effect that was abolished by tolbutamide. The effect of NE on KATP channels was investigated in parallel using outside-out single channel recording. This revealed that NE enhanced the open activities of the KATP channels
2-fold without changing the single channel conductance, demonstrating that NE-induced hyperpolarization was mediated by activation of the KATP channels. The NE effect was abolished in cells preincubated with pertussis toxin, indicating coupling to heterotrimeric Gi/Go proteins. To identify the G proteins involved, antisera raised against
and β subunits (anti-G
common, anti-Gβ, anti-G
i1/2/3, and anti-G
o) were used. Anti-G
common totally blocked the effects of NE on membrane potential and KATP channels. Individually, anti-G
i1/2/3 and anti-G
o only partially inhibited the action of NE on KATP channels. However, the combination of both completely eliminated the action. Antibodies against Gβ had no effects. To confirm these results and to further identify the G protein subunits involved, the blocking effects of peptides containing the sequence of 11 amino acids at the C termini of the
subunits were used. The data obtained were similar to those derived from the antibody work with the additional information that G
i3 and G
o1 were not involved. In conclusion, both Gi and Go proteins are required for the full effect of norepinephrine to activate the KATP channel.
Received for publication, September 13, 2007 , and in revised form, December 7, 2007.
Note Added in Proof—Since the submission of this manuscript, a related article has been published (Katsuya, D., Kakei, M., and Yada, T. (2007) Diabetes 56, 2319–2327).
* This work was supported by National Institutes of Health Grants DK54243 and DK56737 (to G. W. G. S.) and a Career Development Award from the Juvenile Diabetes Foundation International (to S. G. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401. Tel.: 607-253-3875; Fax: 607-253-3659; E-mail: gws2{at}cornell.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |